PRRT2 and prostate cancer: These observed effects are consistent with and secondary to the nuanced MT1 signaling cascade that involves co-activation of parallel PKA (via Gαs) and PKC (via Gαq) cascades that ultimately suppress active NFκB in prostate cancer cells, described earlier in the Cell Cycle Control and Anti-Proliferation section.